Research on Medicine and Vaccine for Covid-19

While COVID-19 vaccines are working well, some people who are completely vaccinated against COVID-19 will still get sick, because no vaccines are 100 effective. These are called vaccine advance cases. The most generally reported side goods were pain at the injection point, frazzle, headache, muscle pain, chills, common pain, and fever. In October 2020, the FDA approved the antiviral medicine remdesivir to treat COVID-19. The medicine may be used to treat grown-ups and children periods 12 and aged and importing at least 88 pounds, who have been rehabilitated for COVID-19. COVID-19 vaccines teach our immune systems how to recognize and fight the virus that causes COVID-19. Sometimes this process can cause symptoms, such as fever.

 

    Related Conference of Research on Medicine and Vaccine for Covid-19

    May 18-19, 2026

    15th World Congress on Rare Diseases and Orphan Drugs

    Prague, Czech Republic
    June 29-30, 2026

    7th Global Experts Meeting on Infectious Diseases

    Singapore City, Singapore
    August 25-26, 2026

    18th Global Conference on Nephrology and Infectious Diseases

    Amsterdam, Netherlands

    Research on Medicine and Vaccine for Covid-19 Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in